PI
-
Regional disparities in the use of intensive chemotherapy for AML in the Netherlands: Does it influence survival?
Kaplan, Z. L. R., van Leeuwen, N., van Klaveren, D., Visser, O., Posthuma, E. F. M., van Lammeren-Venema, D., Snijders, T. J. F., van Elssen, C. H. M. J., van Rhenen, A., von dem Borne, P. A., Blijlevens, N. M. A., Cornelissen, J. J., Raaijmakers, M. H. G. P., van de Loosdrecht, A. A., Huls, G., Lemmens, V. E. P. P., Lingsma, H. F. & Dinmohamed, A. G., 5 Jul 2024, In: BMJ Oncology. 3, 1, e000264.Research output: Contribution to journal › Article › Academic › peer-review
-
Myelodysplastic neoplasms dissected into indolent, leukaemic and unfavourable subtypes by computational clustering of haematopoietic stem and progenitor cells
van Spronsen, M. F., van Gassen, S., Duetz, C., Westers, T. M., Saeys, Y. & van de Loosdrecht, A. A., Jun 2024, In: Leukemia. 38, 6, p. 1365-1377 13 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Benefits and risks of clofarabine in adult acute lymphoblastic leukemia investigated in depth by multi-state modeling
Hermans, S. J. F., van Norden, Y., Versluis, J., Rijneveld, A. W., van der Holt, B., de Weerdt, O., Biemond, B. J., van de Loosdrecht, A. A., van der Wagen, L. E., Bellido, M., van Gelder, M., van der Velden, W. J. F. M., Selleslag, D., van Lammeren-Venema, D., van der Velden, V. H. J., de Wreede, L. C., Postmus, D., Pignatti, F. & Cornelissen, J. J., 1 May 2024, In: Cancer Medicine. 13, 9, e6756.Research output: Contribution to journal › Article › Academic › peer-review
- All publications